Miles Prince
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment
Papers in
- Hematology 25
- Multiple Myeloma Research and Treatments 18
-
- Protein Degradation and Inhibitors 15
- Histone Deacetylase Inhibitors Research 11
- Ubiquitin and proteasome pathways 5
- Co-authors
- John F. Seymour (10 shared papers)Andrew Spencer (7 shared papers)Henry Januszewicz (2 shared papers)Jerome B. Zeldis (4 shared papers)Marta Olesnyckyj (4 shared papers)Robert Knight (4 shared papers)Zhinuan Yu (4 shared papers)Robert S. Ware (1 shared paper)
- Journals
- Blood (37 papers)European Journal of Cancer (2 papers)Journal of Clinical Oncology (1 paper)Journal of Translational Medicine (1 paper)Oncotarget (1 paper)
- Partner nations
- AustraliaUnited StatesFrance
In The Last Decade
Miles Prince
48 papers receiving 648 citations
Peers
Comparison fields: 5 of 53
- Hematology 257
- Pathology and Forensic Medicine 175
- Oncology 234
- Dermatology 64
- Genetics 57
Countries citing papers authored by Miles Prince
This map shows the geographic impact of Miles Prince's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miles Prince with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miles Prince more than expected).
Fields of papers citing papers by Miles Prince
This network shows the impact of papers produced by Miles Prince. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miles Prince. The network helps show where Miles Prince may publish in the future.
Co-authors
The 25 scholars most cited alongside Miles Prince, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 115 | |
| 2 | 2005 | 90 | |
| 3 | 2018 | 57 | |
| 4 | 2008 | 32 | |
| 5 | 2008 | 31 | |
| 6 | 2011 | 30 | |
| 7 | 2011 | 25 | |
| 8 | 2006 | 20 | |
| 9 | 2006 | 18 | |
| 10 | 2005 | 17 | |
| 11 | 2008 | 16 | |
| 12 | 2016 | 16 | |
| 13 | 2009 | 15 | |
| 14 | 2006 | 15 | |
| 15 | 2016 | 14 | |
| 16 | 2006 | 13 | |
| 17 | 2009 | 13 | |
| 18 | 2007 | 12 | |
| 19 | 2007 | 10 | |
| 20 | 2014 | 10 |
About Miles Prince
Miles Prince is a scholar working on Hematology, Molecular Biology, Oncology, Dermatology and Immunology, having authored 49 papers that have together received 667 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (18 papers), Protein Degradation and Inhibitors (15 papers), Histone Deacetylase Inhibitors Research (11 papers), Cutaneous lymphoproliferative disorders research (11 papers), Lymphoma Diagnosis and Treatment (9 papers), Peptidase Inhibition and Analysis (6 papers), Ubiquitin and proteasome pathways (5 papers) and Cancer Treatment and Pharmacology (5 papers). The work is most often cited by research in Hematology (257 citations), Pathology and Forensic Medicine (175 citations), Oncology (234 citations), Dermatology (64 citations) and Genetics (57 citations). Miles Prince has collaborated with scholars based in Australia, United States and France. Frequent co-authors include John F. Seymour, Andrew Spencer, Henry Januszewicz, Jerome B. Zeldis, Marta Olesnyckyj, Robert Knight, Zhinuan Yu, Robert S. Ware, Max Wolf and Michael MacManus. Their work appears in journals such as Blood, European Journal of Cancer, Journal of Clinical Oncology, Journal of Translational Medicine and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.